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Magnetic resonance imaging radiomic 
feature analysis of radiation‑induced 
femoral head changes in prostate cancer 
radiotherapy
ABSTRACT
Background and Purpose: As a feasible approach, radiotherapy has a great role in prostate cancer (Pca) management. However, 
Pca patients have an increased risk of femoral head damages including fractures after radiotherapy. The mechanisms of these 
complications are unknown and time of manifestations is too long; however, they may be predicted by early imaging. The main 
purpose of this study was to assess the early changes in femoral heads in Pca patients treated with intensity‑modulated radiation 
therapy (IMRT) using multiparametric magnetic resonance imaging (mpMRI) radiomic feature analysis.
Materials and Methods: Thirty Pca patients treated with IMRT were included in the study. All patients underwent two mpMRI 
pre‑ and postradiotherapy. Thirty‑four robust radiomic features were extracted from T1, T2, and apparent diffusion coefficient (ADC) 
obtained from diffusion‑weighted images. Wilcoxon signed‑rank test was performed to assess the significance of the change in the 
mean T1, T2, and ADC radiomic features postradiotherapy relative to preradiotherapy values. The percentage change values were 
normalized based on the natural logarithm base ten. Features were also ranked based on their median changes.
Results: Sixty femoral heads were analyzed. All radiomic features have undergone changes. Significant postradiotherapy radiomic 
feature changes were observed in 20 and 5 T1‑ and T2‑weighted radiomic features, respectively (P < 0.05). ADC features did not 
vary significantly postradiotherapy. The mean radiation dose received by femoral heads was 40 Gy. No fractures were observed 
within the follow‑up time. Different features were found as high ranked among T1, T2, and ADC images.
Conclusion: Early structural change analysis using radiomic features may contribute to predict postradiotherapy fracture in Pca 
patients. These features can be identified as being potentially important imaging biomarkers for predicting radiotherapy‑induced 
femoral changes.
KEY WORDS: Feature changes, femoral head, magnetic resonance imaging, prostate cancer, radiomics, radiotherapy
Original Article
INTRODUCTION
Prostate cancer (Pca) is the most common malignancy 
among men. As a feasible approach, radiotherapy has 
a great role in Pca management. However, normal 
tissue toxicities during or after radiotherapy remain 
the main limiting factors with negative impacts on 
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patient’s quality of life.[1] Radiation-associated femoral 
head/neck toxicities including fractures, cortical bone 
thinning, and necrosis are complications which may 
occur months to years after radiotherapy.[2,3] Previous 
studies have indicated that femoral insufficiency 
fracture is significantly higher in patients who receive 
pelvic irradiation.[4,5] Femoral head fractures due to 
radiotherapy are associated with high morbidity and 
significant mortality.
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Although the mechanisms by which radiation induces bone 
damages have been studied extensively, they remain unclear. 
Some studies have revealed that radiotherapy changes 
the biomechanical properties of bones including matrix 
embrittlement.[6] Furthermore, previous research has shown that 
radiotherapy suppresses normal osteoblast proliferation.[7] It was 
also shown that radiation sensitizes bone cells to apoptosis.[8]
Magnetic resonance imaging (MRI) can be utilized as a feasible 
modality to detect bone abnormities.[9,10] MR image sequences 
including T1-weighted (T1W), T2W, and diffusion-weighted (DW) 
are of importance in bone disease diagnosis.[11] On the other 
hand, apparent diffusion coefficient (ADC), which is proportional 
to the cellular density, ratio of extracellular and intracellular 
components, and also soluble intracellular macromolecules, has 
been used in differentiating and detecting bone pathologies.[12]
Recent advances in image analysis and biomarker research 
have produced powerful platforms for diagnosis, prognosis 
prediction, and therapeutic management of diseases.[13] As 
an important current and future-based science, radiomics 
have been used to quantify tumor characteristics and also 
radiotherapy-associated clinical manifestations.[14,15] It is a 
newly accepted branch of image processing which aims to 
correlate high-dimensional imaging features with clinical 
data. Furthermore, in radiomic literature, changes in different 
imaging features were correlated with radiation dose[16] and 
clinical observations such as tissue shrinkage or density 
changes and hearing loss.[17-19]
In the present study, for the first time, we applied radiomic 
feature analysis on MR images with the aim to assess changes 
in femoral head after the course of radiotherapy.
MATERIAL AND METHODS
Our radiomic flowchart is depicted in Figure 1. From Figure 1, 
our study is composed of four continuing phases including 
(1) imaging and segmentation, (2) image preprocessing, 
(3) feature extraction, and (4) data analysis.
Study participants
In this prospective study, to test how radiotherapy induces 
femoral head changes, we conducted an MR image radiomic 
Figure 1: Radiomic flowchart
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feature analysis. Between January 2015 and September 2016, 
we enrolled 30 Pca patients, with different Gleason scores, 
in accordance with the ethical standards of the responsible 
committee on human experimentation and in compliance 
with the 1975 Declaration of Helsinki and its revision in 
2000. Because this work was conducted as prospective, 
all participants gave informed consent before enrollment. 
Patients were treated with intensity-modulated radiation 
therapy (IMRT), with 70.6 Gy in 25 fractions and treatment 
was delivered with multileaf collimators using 9 coplanar or 
noncoplanar, nonuniform beams. All planning was performed 
using Eclipse treatment planning system (Varian Medical 
Systems). In the plans, both right and left femoral heads 
were delineated as organs at risk and their mean radiation 
doses were obtained from TPS and their relevant dose volume 
histograms. The patients were followed for 6 months to 1 year 
for postradiotherapy bone damages. The patient details are 
shown in Table 1.
Magnetic resonance imaging
All participants underwent two MRI scans, pre- and 
postradiotherapy. The mean time for MR scanning after 
radiotherapy was 3 months. Both pre- and postradiotherapy 
MRI scans included T1W, T2W, and DW imaging protocols. 
All studies were performed using 1.5 Tesla MRI machines 
(Siemens and Philips) equipped with endorectal and 
phased-array coils. The imaging protocols are shown in 
Table 2. For each patient, MR image protocols were the same 
in pre- and postradiotherapy scans. ADC was automatically 
calculated by the imager software with the use of the b-values 
reported in Table 2.
Radiomic features
Multiple radiomic feature sets including histogram, 
co-occurrence gray-level matrix (GLCM),  gray-level run length 
matrix, gray-level zone length matrix, and neighborhood 
gray-level difference matrix were applied on MR images. The 
robustness of these features was tested in previous studies.[20-22] 
Table 3 shows the details of these features. For radiomic 
analysis, femoral heads were segmented in each slice on T1W, 
T2W, and ADC images and obtained three-dimensional (3D) 
regions of interest were used for feature analysis. To reduce 
interobserver variability, all femoral heads were segmented 
by an experienced radiation oncologist physicist. All 
segmentations were done manually and verified by an 
experienced radiologist (more than 10 years’ experiences in 
musculoskeletal imaging). Before feature extraction, all image 
intensities were discretized to 64 gray levels, in order to image 
noise reduction, increasing sensitivity, and normalizing the 
intensities across all the patients.
Statistical analysis
All statistical analyses were performed using STATA 
(Version 11.1, SE Texas). Wilcoxon signed-rank test was 
performed to assess the significance of the change in 
mean T1W, T2W, and ADC radiomic features postradiotherapy 
relative to preradiotherapy values. Statistical significance 
was assumed if P < 0.05 and all reported P values are two 
sided. The percentage changes of the postradiotherapy to the 
preradiotherapy for all radiomic features were also calculated 
to show the relative changes postradiation. The percentage 
change values were normalized based on the natural logarithm 
base 10. This ensured that the different parameter values were 
in a comparable range of values when quantifying differences 
between pre- and postradiotherapy.
RESULTS
All radiomic features in T1W/T2W/ADC images had difference 
between pre- and postradiotherapy. Normalized percentage 
changes with 95% confidence intervals of these features are 
shown in Figures 2-4. We also showed the MRI radiomic features 
ranking in Table 4. Features ranked in the descending order 
based on the median values.  High rank features showing 
Table 2: Imaging protocols from two scanners
Scanners/imaging protocol Siemens Philips
T1w T2w DW T1w T2w DW
Slice thickness (mm) 3 3 3.5 3.5 3.5 5
Repetition time (TR) (ms) 563 3000 3900 509 3065 4600
Echo time (TE) (ms) 14 101 100 10 80 90
Acquisition matrix 256×224 256×205 150×150 300×278 300×262 120×122
b-value (s/mm2) - - 1200 - - 1000
Table 1: Patient details participating in this study
Characteristic Value















Femoral head dose Right Left
Mean 40.9 39.7
Range 0.9‑52.6 23.6‑52.7
PSA=Prostate‑specific antigen, IMRT=Intensity‑modulated radiation therapy, 
RT=Radiation therapy
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Table 3: Radiomic features
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Table 3: Contd...
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GLCM=Co-occurrence gray-level matrix, GLRLM=Gray-level run length matrix, GLZLM=Gray-level zone length matrix, NGTDM=Neighborhood gray-level difference 
matrix, NGLDM=Neighborhood gray-level different matrix
high pre/postradiotherapy changes. Wilcoxon signed-rank 
test revealed that 20 T1W radiomic features vary significantly 
postradiotherapy. These features are shown in Table 5. On the 
contrary, ADC features did not vary significantly postradiotherapy. 
In regard to T2W radiomic features, only five features had 
significant changes postradiotherapy. The features ENTROPY_
HISTOGRAM (P = 0.004), CONTRAST_GLCM (P = 0.018), 
ENTROPY_GLCM (P = 0.009), DISSIMILARITY_GLCM (P = 0.02), 
and CONTRAST_NGLDM (P = 0.013) have undergone significant 
changes due to radiotherapy. There was no significant correlation 
between mean radiation dose and radiomic feature changes. 
Furthermore, no fractures were observed within the follow-up 
Abdollahi, et al.: Femoral head radiomic analysis
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time; hence, the correlation between radiomic feature changes 
and fracture could not be assessed.
DISCUSSION
Radiation-induced bone complications have been observed in 
different patient populations undergoing radiotherapy.[23] In a 
cohort study, Elliott et al. found that the risk of hip fractures 
significantly increases up to 76% in 45,662 Pca patients 
undergoing radiotherapy.[24] In another previous retrospective 
and randomized prospective trials, pelvic insufficiency 
and hip fractures have been reported in patients treated 
for pelvic malignancies.[25] In this clinical study, we 
demonstrated the feasibility of radiomic features to assess 
the radiotherapy-induced femoral head changes. We observed 
that all selected radiomic features have undergone changes 
and significant differences in 20 T1 and 5 T2 radiomic features 
between the pre- and postradiotherapy femoral heads.
In radiomic studies, any feature has its own concept and 
changes in their values could show structural and functional 
changes of the tissues being studied. For example, energy is 
associated with overall homogeneity. In our study, this feature 
has been changed in the postradiotherapy femoral heads, 
suggesting changed level of heterogeneity. Furthermore, 
contrast shows the difference between the highest and the 
lowest pixel values and is a measure of image local variations. 
Changes in this feature indicate that image has undergone 
large variations due to exposure to radiation.
A further finding of our work was that radiomic features 
obtained from different MR image sequences have different 
behaviors against radiotherapy. As shown in Figures 2-4, some 
features had positive percentage changes in T1 and they had 
negative changes in T2 or ADC and vice versa. A possible 
explanation for this might be that MRI sequences (T1W/T2W/
ADC) have different image acquisition mechanisms and these 
lead to different image features and feature response.
In recent years, researchers have investigated a variety of MRI 
for bone diseases detection, characterization, and classification 
using ADC, but to best of our knowledge, there is no report 
on the bone ADC feature analysis. In the present work, we 
showed that radiotherapy induces changes in ADC features, 
although statistical analysis showed that these changes are 
nonsignificant. It is also should be considered that b‑value has 
a direct impact on ADC features. In our work, we used fixed 
b‑values and in future works may use different values to assess 
radiotherapy-induced damages.
In regard with the role of image feature analysis for bone 
insufficiency, there are some interesting studies. Nardone 
et al. examined the role of texture analysis (TA) as a predictive 
factor of radiation-induced insufficiency fractures (IFs). 
In this study, they performed femoral head computed 
tomography (CT)-simulation texture analysis of patients 
undergoing pelvic radiotherapy and concluded that bone 
CT-TA could be correlated to the risk of radiation-induced IFs.[26] 
They also repeated their work with (3D) TA and found that 
3D-bone CT-TA can be used to stratify the risk of the patients to 
develop radiation-induced IFs.[27] In another study, Rachidi et al. 
explored Laws’ masks analysis to describe structural variations 
of trabecular bone due to osteoporosis on digital radiographs 
and found that this method constitutes a promising routine 
Figure 2: T1-weighted radiomic features – percentage Change 
(normalized) with 95% confidence intervals. Features with significant 
changes were shown with *
Figure 4: Apparent diffusion coefficient radiomic features – percentage 
change (normalized) with 95% confidence intervals. Features with 
significant changes were shown with*
Figure 3: T2-weighted radiomic features – percentage change 
(normalized) with 95% confidence intervals. Features with significant 
changes were shown with *
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Table 4: Magnetic resonance imaging radiomic features ranking. Features ranked in the descending order based on median 
values (absolute). High rank features showing high pre/postradiation therapy changes
Rank T1W features T2W features ADC features
1 COARSENESS_NGLDM COARSENESS_NGLDM SRE_GLRLM
2 LRLGE_GLRLM LZE_GLZLM SZE_GLZLM
3 LZLGE_GLZLM ENERGY_HISTOGRAM RP_GLRLM
4 ENERGY_HISTOGRAM ENERGY_GLCM BUSYNESS_NGLDM
5 HOMOGENEITY_GLCM LRE_GLRLM ENTROPY_GLCM
6 SZLGE_GLZLM SZLGE_GLZLM LRE_GLRLM
7 RLNU_GLRLM ENTROPY_HISTOGRAM RLNU_GLRLM
8 GLNU_GLRLM SKEWNESS_HISTOGRAM ZP_GLZLM
9 ZLNU_GLZLM LRLGE_GLRLM ENTROPY_HISTOGRAM
10 LRE_GLRLM ENTROPY_GLCM HOMOGENEITY_GLCM
11 LZE_GLZLM CONTRAST_NGLDM COARSENESS_NGLDM
12 GLNU_GLZLM LZLGE_GLZLM HGZE_GLZLM
13 LGZE_GLZLM GLNU_GLRLM SRHGE_GLRLM
14 SRE_GLRLM SRE_GLRLM DISSIMILARITY_GLCM
15 RP_GLRLM SRLGE_GLRLM LGZE_GLZLM
16 ZP_GLZLM RP_GLRLM HGRE_GLRLM
17 KURTOSIS_HISTOGRAM LGRE_GLRLM LZHGE_GLZLM
18 SKEWNESS_HISTOGRAM ZP_GLZLM LZLGE_GLZLM
19 CONTRAST_NGLDM CONTRAST_GLCM LGRE_GLRLM
20 HGZE_GLZLM LGZE_GLZLM CONTRAST_NGLDM
21 LGRE_GLRLM SZE_GLZLM SRLGE_GLRLM
22 ENTROPY_HISTOGRAM GLNU_GLZLM LZE_GLZLM
23 SZE_GLZLM KURTOSIS_HISTOGRAM SZHGE_GLZLM
24 CORRELATION_GLCM RLNU_GLRLM ZLNU_GLZLM
25 CONTRAST_GLCM HOMOGENEITY_GLCM CONTRAST
26 SRHGE_GLRLM SZHGE_GLZLM ENERGY_HISTOGRAM
27 SZHGE_GLZLM ZLNU_GLZLM SZLGE_GLZLM
28 HGRE_GLRLM HGZE_GLZLM CORRELATION_GLCM
29 ENERGY_GLCM CORRELATION_GLCM KURTOSIS_HISTOGRAM
30 ENTROPY_GLCM DISSIMILARITY_GLCM GLNU_GLZLM
31 SRLGE_GLRLM SRHGE_GLRLM GLNU_GLRLM
32 LRHGE_GLRLM BUSYNESS_NGLDM SKEWNESS_HISTOGRAM
33 DISSIMILARITY_GLCM HGRE_GLRLM ENERGY_GLCM
34 BUSYNESS_NGLDM LRHGE_GLRLM LRLGE_GLRLM
GLCM=Co-occurrence gray-level matrix, GLRLM=Gray-level run length matrix, GLZLM=Gray-level zone length matrix, NGTDM=Neighborhood gray-level 
difference matrix, ADC=Apparent diffusion coefficient
technique for the determination of osteoporosis fracture risk 
from radiographs.[28] On the other hand, in a study by Thevenot 
et al., it was found that femoral neck fracture can be predicted 
on the basis of clinical radiographs using the combined 
analysis of bone geometry, textural analysis of trabecular bone, 
and bone mineral density.[29]
Dose–volume effect for radiotherapy-induced femoral head 
damages has been reported in several studies and some 
of which indicated that there are no well-established dose 
constraints for femoral head.[1] Emami et al. and Bedford et al. 
introduced a 52 Gy tolerance dose for the whole organ and 
10% of the organ for probability of complication below 5%, 
respectively.[30,31] In our study, despite the use of IMRT, the 
mean radiation dose received by femoral head was 40 Gy and 
there was no correlation between radiation dose and feature 
changes. In a recent study, Okoukoni et al. observed significant 
postradiotherapy cortical thinning in the intertrochanteric 
crest of femoral neck. They also identified that there is a 
correlation between radiation dose and cortical thinning.[2]
Based on previous studies and as was reviewed by Zhang et al., 
due to the different responses of bone cells to radiotherapy 
including differentiation and radiosensitivity, the underlying 
mechanisms are different at different doses.[32] However, 
studies have indicated that, following the radiotherapy, the 
initial changes in bone result from injury to the remodeling 
system (osteocytes, osteoblasts, and osteoclasts) which 
is result of direct irradiation injury to the cells of the 
remodeling system or the indirect result of irradiation-induced 
vascular injury, or a combination of both phenomena.[33] 
For radiation-associated fractures, the believed mechanism 
is radiation-induced vascular fibrosis and impairment of 
osteoblast cells, which can lead to avascular necrosis and 
bone atrophy, therefore leaving bone susceptible to fracture.[34] 
There are also some reports associating bone damages with 
radiation-induced cortical thinning, reduced bone mechanical 
properties, and reduced bone plasticity.[35]
This is the first study to demonstrate the association between 
radiotherapy-induced femoral head damages and MRI 
radiomic feature changes and there is a lack of prior research 
studies on the topic. In similar works, different image texture 
analyses have been used to assess radiotherapy-induced 
shrinkage in parotid.[36,37] In these studies, a little number 
of textural features were extracted from CT scanning and 
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sonography and their results are specific. In comparison to 
these studies, we extracted several multiparametric MRI 
radiomic features from different feature categories and our 
results are different.
Although our results are original and significant, there are 
limitations associated with this study. First is the number 
of patients. Future studies will validate our findings on a 
larger cohort of data. Second is the time of postradiotherapy 
follow-up. Clinically, radiation-induced femoral head damages 
often take years to develop after radiotherapy and further 
long-term follow-up is needed to have more clinically results. 
However, the present study is a rapid postradiotherapy 
test and our results indicated that early structural change 
analysis using radiomic features may contribute to predict 
postradiotherapy fracture in these patients. Furthermore, 
these features can be identified as potentially important 
imaging biomarkers for radiotherapy-induced femoral 
fractures or any other complications prediction.
CONCLUSION
MR radiomic feature analysis is a feasible approach for 
radiotherapy-induced bone damage assessment. These 
features may be considered as fast, noninvasive, and predictive 
imaging biomarkers for routine clinical use.
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